Evaluation of a Quality‐of‐Life Tool for Dogs with Diabetes Mellitus

Niessen, Stijn; Powney, S L; Guitian, Javier; Niessen, A P M; Pion, Paul D.; Shaw, James; Church, David

doi:10.1111/j.1939-1676.2012.00947.x

Cited by 55 publications

(62 citation statements)

References 15 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent study evaluated the psychological and social impact of diabetes and its treatment on the quality of life of 101 owners of diabetic dogs living in the United Kingdom, United States, Canada, Australia, and Europe (Niessen et al, 2012). A recent study evaluated the psychological and social impact of diabetes and its treatment on the quality of life of 101 owners of diabetic dogs living in the United Kingdom, United States, Canada, Australia, and Europe (Niessen et al, 2012).…”

Section: Goals Of Therapymentioning

confidence: 99%

Canine Diabetes Mellitus

Nelson¹

2015

Canine and Feline Endocrinology

View full text Add to dashboard Cite

Section: Goals Of Therapymentioning

confidence: 99%

Canine Diabetes Mellitus

Nelson¹

2015

Canine and Feline Endocrinology

View full text Add to dashboard Cite

“…Corrected item total correlations, a representation of how much each individual item correlates with the scale, also were calculated, and a value >0.30 was considered ideal . Inclusion and exclusion of items was based on assessment of the combination of the extraction communalities, factor loadings, corrected item total correlation, the value for Cronbach's α if the item was deleted, and assessment of the frequency and importance values of items, consistent with good psychometric practice . After exclusion of items that negatively affected the validity of the QoL tool, PCA and reliability analysis were repeated and all values re‐assessed to investigate whether additional exclusions and analyses were needed.…”

Section: Methodsmentioning

confidence: 99%

“…Veterinary QoL assessments published to date vary from linear analog scales asking owners to rate their pets' QoL on a scale of 1–10, to a handful of psychometrically validated multi‐question general health QoL tools . In addition, various disease‐specific tools are available, such as questionnaires for use in cats with heart disease, and a tool for both dogs and cats with cancer and diabetes . To date, no psychometrically validated general tool is available to assess health‐related QoL in cats.…”

mentioning

confidence: 99%

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease

Bijsmans

Jepson

Syme

et al. 2015

Veterinary Internal Medicne

Self Cite

View full text Add to dashboard Cite

BackgroundNumerous validated psychometric tools are available to assess impact of disease on a human's quality of life (QoL). To date, no psychometrically validated general health‐related QoL tool exists for cats.Hypothesis/ObjectivesTo develop and validate a tool for assessment of owner‐perceived QoL in cats (CatQoL) and to use this tool to compare QoL between healthy cats and those with chronic kidney disease (CKD).Animals/SubjectsTotal of 204 owners of young healthy cats (YH, n = 99; <9 years), older healthy cats (OH, n = 35), and cats diagnosed with CKD (CKD, n = 70) completed the CatQoL.MethodsDiscussions with a focus group and 2 pilot surveys informed design of 16 QoL questions grouped into 4 domains. Each item scored according to frequency and importance, and item‐weighted‐impact‐scores were calculated. The validity of the tool was assessed using principal components analysis and Cronbach's α. The average item‐weighted‐impact‐score (AWIS) was compared among groups and domains.ResultsSixteen‐item CatQoL showed good internal consistency reliability (Cronbach's α, 0.77) and unidimensionality with significant loadings (0.2–0.7) and communalities (>0.3). Young healthy cats had significantly higher AWIS (median [IQR], 1.25 [0.63, 1.88]) than OH (0.56 [−0.06, 1.00]) and CKD cats (−0.06 [−0.81, 0.88]), P < .001). CKD cats had significantly lower AWIS for eating domain (YH: 2.00 [1.00, 3.00]; OH: 2.00 [0.67, 3.00]; CKD : 1.00 [0.00, 2.67]) when compared with the YH group and OH group, and all groups differed significantly in their management domain (YH: −0.50 [−1.00, 0.00]; OH: −1.00 [−1.88, −0.50]; CKD : −1.50 [−2.50, −1.00], P < .001).Conclusions and Clinical ImportanceThe CatQoL was validated for use in cats, and can be used as additional assessment parameter in clinical and research settings.

show abstract

“…The aims of the treatment are to: a) control the clinical manifestations of the disease, b) avoid complications of DM such as diabetic ketosis and acidosis, cataract formation (especially in dogs) and polyneuropathy (especially in cats), c) control blood glucose concentrations throughout the day, ideally below the renal threshold for glycosuria (i.e. 175-220 mg dl -1 for dogs and 210-290 mg dl -1 for cats), d) avoid treatment complications, especially hypoglycemia, e) improve the quality of life of the diabetic dog or cat and the owner, and f) achieve diabetic remission in cats (Martin and Rand, 2007a;Zerrenner et al, 2007;Marshall et al, 2009;Niessen et al, 2010Niessen et al, , 2012Smith et al, 2012;Caney, 2013).…”

mentioning

confidence: 99%

Update on insulin treatment of dogs and cats with non-complicated diabetes mellitus

Saridomichelakis

Chatzis

2018

J Hellenic Vet Med Soc

View full text Add to dashboard Cite

ABSTRACT. Diabetes mellitus is a common endocrine disease of dogs and cats. Treatment is mainly based on insulin administration and dietary modifications. The aim of this review is to provide updated information on insulin treatment of dogs and cats with non-complicated diabetes mellitus. During the last years, there has been significant progress in the management of this disease, thanks to the use of long-acting insulin preparations that do not cause pronounced fluctuations of blood glucose concentrations (insulin glargin and detemir) and because of the widespread use of home glucose monitoring by the owners of diabetic pets. Home glucose monitoring is based on capillary blood sampling from the ear pinnae or the foot pad and measurement of blood glucose concentration with a portable blood glucose meter. This can be done periodically (e.g. every week) to replace the traditional in-clinic blood glucose curve; in this case, blood glucose concentration is measured just before the morning insulin administration and then every 1-2 hours until the next dose (usually for 12 hours). Furthermore, especially for the cat, home glucose monitoring can be performed 3-5 times per day, on a daily basis, in order to safely adjust insulin dose and achieve tight control of hyperglycemia (i.e. blood glucose concentration between 50 and 200 mg dl -1 throughout the day). The combination of dietary management, of insulin glargine or detemir administration and of the tight control of hyperglycemia has substantially increased the proportion of cats that enter into temporal or permanent diabetic remission and can be further managed without insulin. Another important achievement is the use of continuous glucose monitoring systems to monitor interstitial fluid glucose concentrations. These devices can be used in the clinic and at home and they can measure glucose concentration every 5 minutes for up to 72 consecutive hours, thus facilitating optimal adjustment of insulin treatment.

show abstract

Evaluation of a Quality‐of‐Life Tool for Dogs with Diabetes Mellitus

Cited by 55 publications

References 15 publications

Canine Diabetes Mellitus

Canine Diabetes Mellitus

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease

Update on insulin treatment of dogs and cats with non-complicated diabetes mellitus

Contact Info

Product

Resources

About